Boston Scientific (BSX) Short-Term Debt issuances (2017 - 2026)

Boston Scientific (BSX) has 9 years of Short-Term Debt issuances data on file, last reported at $259.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short-Term Debt issuances fell 76.08% year-over-year to $259.0 million; the trailing twelve-month figure through Mar 2026 stood at $771.0 million (down 28.81% YoY), and the FY2025 full-year result was $1.6 billion, up 216.47% from the prior year.
• Short-Term Debt issuances climbed to $259.0 million in Q1 2026, from $12.0 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $1.1 billion in Q1 2025 to a low of -$504.0 million in Q3 2024.
• A 5-year average of $196.5 million and a median of $143.5 million in 2022 frame the typical range for Short-Term Debt issuances.
• Across the five-year window, Short-Term Debt issuances plunged 1262.16% in 2024 and jumped 114.88% in 2025, its largest moves.
• Tracing BSX's Short-Term Debt issuances over 5 years: stood at $1.0 million in 2022, then tumbled by 3800.0% to -$37.0 million in 2023, then surged by 1462.16% to $504.0 million in 2024, then sank by 97.62% to $12.0 million in 2025, then soared by 2058.33% to $259.0 million in 2026.
• Business Quant data shows BSX's Short-Term Debt issuances at $259.0 million in Q1 2026, $12.0 million in Q3 2025, and $500.0 million in Q2 2025.